Direktorat Registrasi ObatValid

CEFOTAXIME SODIUM

Claim this product
BPOM Number
GKL2442601644A1
Approved
21 November 2024
Expiry
17 September 2029
Form
SERBUK INJEKSI; 1.05 G

About This Registration

CEFOTAXIME SODIUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2442601644A1. Its current registration status is Valid, with the licence valid until 17 September 2029. The product is registered to SATORIA ANEKA INDUSTRI - INDONESIA. BPOM first approved this registration in September 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 10 VIAL @ 1 G
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

CEFOTAXIME SODIUM

Market Intelligence

Owner Portfolio
SATORIA ANEKA INDUSTRI - INDONESIA holds 45 BPOM registrations
Manufacturer Scale
SATORIA ANEKA INDUSTRI - INDONESIA produces 45 registered products
Registration Age
Registered for 1 year, 9 months

FDA Cross-Reference

via openFDA
Generic Name
CEFOTAXIME INJECTION
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1